SARS-CoV-2 (COVID-19) coronavirus infection and the gastrointestinal tract Review article
Article Sidebar
Published:
Mar 31, 2020
Keywords:
coronavirus, gastrointestinal tract, inflammatory bowel disease, prevention in endoscopy units
Main Article Content
Abstract
Although the main coronavirus SARS-CoV-2 manifestation is acute respiratory disease, gastrointestinal symptoms may also occur. The predominant way of coronavirus spreading consists of droplet transmission, but the fecal-oral way is also probable. At the pandemic period highly strict epidemiological standards need to be respected either at gastroenterology health services or endoscopy units. Patients with chronic gastrointestinal conditions, especially receiving immunosuppressive and immunomodulatory therapy, should be isolated and supported remotely with the use of telemedicine communication.
Article Details
How to Cite
Radwan, K. (2020). SARS-CoV-2 (COVID-19) coronavirus infection and the gastrointestinal tract. Medycyna Faktow (J EBM), 13(1(46), 36-42. https://doi.org/10.24292/01.MF.0120.3
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. Guan W.J., Ni Z.Y., Hu Y. et al.: Clinical characteristics of 2019 novel coronavirus infection in China. N. Engl. J. Med. 2020. https://doi.org/10.1056/NEJMoa2002032.
2. Chan J.F., Kok K.H., Zhu Z. et al.: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 2020; 9: 221-236.
3. Chan K.H., Poon L.L., Cheng V.C. et al.: Detection of SARS coronavirus in patients with suspected SARS. Emerg. Infect. Dis. 2004; 10: 294-99.
4. Mackay I.M., Arden K.E.: MERS coronavirus: diagnostics, epidemiology and transmission. Virol. J. 2015; 12: 222.
5. Wang D., Hu B., Hu C. et al.: Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020. https://doi.org/10.1001/jama.2020.1585.
6. Gu J., Han B., Wang J.: COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2020. https://doi.org/10.1053/j.gastro.2020.02.054.
7. Huang Ch., Wang Y., Li X. et al.: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497-506.
8. Chen N., Zhou M., Dong X. et al.: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395: 507-513.
9. Pan L., Mu M., Ren H.G. et al.: Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am. J. Gastroenterol. 2020; https://doi.org/10.14309/ajg.0000000000000620.
10. Yang X., Yu Y., Xu J. et al.: Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med. 2020. https://doi.org/10.1016/S2213-2600(20)30079-5.
11. Lu R., Zhao X., Li J. et al.: Genomic characterisationand epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020. https://doi.org/10.1016/S0140-6736(20)30251-8.
12. Wan Y., Shang J., Graham R. et al.: Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J. Virol. 2020. https://doi.org/10.1128/JVI.00127-20.
13. Huang Q., Herrmann A.: Fast assessment of human receptor-binding capability of 2019 novel coronavirus (2019-nCoV). Preprint bioRxiv 2020. https://doi.org/10.1101/2020.02.01.930537.
14. Yeo C., Kaushal S., Yeo D.: Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible? Lancet Gastroenterol. Hepatol. 2020. https://doi.org/10.1016/S2468-1253(20)30048-0.
15. Holshue M.L., DeBolt C., Lindquist S. et al.: First Case of 2019 Novel Coronavirus in the United States. N. Engl. J. Med. 2020; 382(10): 929-936. https://doi.org/10.1056/NEJMoa2001191.
16. To K.K., Tsang O.T., Chik-Yan Yip C. et al.: Consistent detection of 2019 novel coronavirus in saliva. Clin. Infect. Dis. 2020. https://doi.org/10.1093/cid/ciaa149.
17. Song Y., Liu P., Shi X.L. et al.: SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19. Gut. 2020. https://doi.org/10.1136/gutjnl-2020-320891.
18. Guan G.W., Gao L., Wang J.W. et al.: [Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia]. Zhonghua Gan Zang Bing Za Zhi. 2020; 28: E002. https://doi.org/10.3760/cma.j.issn.1007-3418.2020.02.002.
19. Chai X.Q., Hu L.F., Zhang Y. et al.: Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection. Preprint bioRxiv 2020. https://doi.org/10.1101/2020.02.03.931766.
20. Danese S., Cecconi M., Spinelli A.: Management of IBD during the COVID-19 outbreak: resetting clinical priorities. Nat. Rev. Gastroenterol. Hepatol. 2020. https://doi.org/10.1038/s41575-020-0294-8.
21. IOIBD: IOIBD Update on COVID19 for Patients with Crohn’s Disease and Ulcerative Colitis.
22. UEG: COVID-19 & Digestive Health. 27.03.2020.
23. Rejestr SECURE-IBD (Surveillance Epidemiology of Coronavirus Under Research Exclusion).
24. Mao R., Liang J., Shen J. et al.: Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol. Hepatol. 2020. https://doi.org/10.1016/S2468-1253(20)30076-5.
25. Repici A., Maselli R., Colombo M. et al.: Coronavirus (COVID-19) outbreak: what the department of endoscopy should know. Gastrointest. Endosc. 2020. https://doi.org/10.1016/j.gie.2020.03.019.
26. Marek T., Reguła J., Rydzewska G.: Wytyczne Polskiego Towarzystwa Gastroenterologii i konsultanta krajowego w dziedzinie gastroenterologii dotyczące wykonywania endoskopii przewodu pokarmowego w związku z epidemią COVID-19 (z dnia 16.03.2020).
2. Chan J.F., Kok K.H., Zhu Z. et al.: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 2020; 9: 221-236.
3. Chan K.H., Poon L.L., Cheng V.C. et al.: Detection of SARS coronavirus in patients with suspected SARS. Emerg. Infect. Dis. 2004; 10: 294-99.
4. Mackay I.M., Arden K.E.: MERS coronavirus: diagnostics, epidemiology and transmission. Virol. J. 2015; 12: 222.
5. Wang D., Hu B., Hu C. et al.: Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020. https://doi.org/10.1001/jama.2020.1585.
6. Gu J., Han B., Wang J.: COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2020. https://doi.org/10.1053/j.gastro.2020.02.054.
7. Huang Ch., Wang Y., Li X. et al.: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497-506.
8. Chen N., Zhou M., Dong X. et al.: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395: 507-513.
9. Pan L., Mu M., Ren H.G. et al.: Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am. J. Gastroenterol. 2020; https://doi.org/10.14309/ajg.0000000000000620.
10. Yang X., Yu Y., Xu J. et al.: Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med. 2020. https://doi.org/10.1016/S2213-2600(20)30079-5.
11. Lu R., Zhao X., Li J. et al.: Genomic characterisationand epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020. https://doi.org/10.1016/S0140-6736(20)30251-8.
12. Wan Y., Shang J., Graham R. et al.: Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J. Virol. 2020. https://doi.org/10.1128/JVI.00127-20.
13. Huang Q., Herrmann A.: Fast assessment of human receptor-binding capability of 2019 novel coronavirus (2019-nCoV). Preprint bioRxiv 2020. https://doi.org/10.1101/2020.02.01.930537.
14. Yeo C., Kaushal S., Yeo D.: Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible? Lancet Gastroenterol. Hepatol. 2020. https://doi.org/10.1016/S2468-1253(20)30048-0.
15. Holshue M.L., DeBolt C., Lindquist S. et al.: First Case of 2019 Novel Coronavirus in the United States. N. Engl. J. Med. 2020; 382(10): 929-936. https://doi.org/10.1056/NEJMoa2001191.
16. To K.K., Tsang O.T., Chik-Yan Yip C. et al.: Consistent detection of 2019 novel coronavirus in saliva. Clin. Infect. Dis. 2020. https://doi.org/10.1093/cid/ciaa149.
17. Song Y., Liu P., Shi X.L. et al.: SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19. Gut. 2020. https://doi.org/10.1136/gutjnl-2020-320891.
18. Guan G.W., Gao L., Wang J.W. et al.: [Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia]. Zhonghua Gan Zang Bing Za Zhi. 2020; 28: E002. https://doi.org/10.3760/cma.j.issn.1007-3418.2020.02.002.
19. Chai X.Q., Hu L.F., Zhang Y. et al.: Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection. Preprint bioRxiv 2020. https://doi.org/10.1101/2020.02.03.931766.
20. Danese S., Cecconi M., Spinelli A.: Management of IBD during the COVID-19 outbreak: resetting clinical priorities. Nat. Rev. Gastroenterol. Hepatol. 2020. https://doi.org/10.1038/s41575-020-0294-8.
21. IOIBD: IOIBD Update on COVID19 for Patients with Crohn’s Disease and Ulcerative Colitis.
22. UEG: COVID-19 & Digestive Health. 27.03.2020.
23. Rejestr SECURE-IBD (Surveillance Epidemiology of Coronavirus Under Research Exclusion).
24. Mao R., Liang J., Shen J. et al.: Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol. Hepatol. 2020. https://doi.org/10.1016/S2468-1253(20)30076-5.
25. Repici A., Maselli R., Colombo M. et al.: Coronavirus (COVID-19) outbreak: what the department of endoscopy should know. Gastrointest. Endosc. 2020. https://doi.org/10.1016/j.gie.2020.03.019.
26. Marek T., Reguła J., Rydzewska G.: Wytyczne Polskiego Towarzystwa Gastroenterologii i konsultanta krajowego w dziedzinie gastroenterologii dotyczące wykonywania endoskopii przewodu pokarmowego w związku z epidemią COVID-19 (z dnia 16.03.2020).